Delivery Order SPE2DR25D1053-SPE2DR26FT071
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.04 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count supply) with a ceiling value of $1,936.74. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to conclude on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, valued at $1,812.56, for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count supply) with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 5-160 mg tablets (30-count) under a firm fixed-price contract valued at $1,129.61. The order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,700.58 to AmerisourceBergen Drug Corp for Amlodipine-Valsartan 5-160 mg tablets (30-count) on September 8, 2025, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,161.72 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Amlodipine-Valsartan 5-160 mg tablets (30-count units) valued at $23,768.80. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by September 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,611.56 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) on May 6, 2025, with completion scheduled for May 7, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency has awarded a delivery order valued at $8,336.56 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Amlodipine-Valsartan is a combination antihypertensive medication used in the treatment...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT071Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,381.68 to AmerisourceBergen Drug Corp for Amlodipine-Valsartan 10-320 mg tablets (30-count) on October 20, 2025, with completion scheduled for October 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies military and veteran healthcare systems with a comprehensive range of pharmaceutical products, medical supplies, and specialized healthcare commodities. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The underlying contract represents part of DLA's broader pharmaceutical procurement strategy and demonstrates the contractor's established capability to fulfill federal medical supply requirements through competitive delivery order mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 10/20/25 |